Loading…
← CockpitCompetitor Analysis › PARASHLTH.NS Paras Healthcare LimitedOpen in the cockpit ↗

Paras Healthcare LimitedPARASHLTH.NSCompetitor analysis, valuation and peers

India · INR·Pharma & Healthcare›Hospital/Nursing Management
Mkt cap
$962M
US dollars, full cap
$/day
$14.2M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-4.9 pp
WACC 12.6%
Hurdle
n/a
no reverse DCF
Next earnings
105 days
3 Mar 2027
Close · INR₹829.80
1D-5.8%
1W+2.9%
1Mn/a
3Mn/a
6Mn/a
YTDn/a
1Yn/a
ATR %6.6%
52w lowhigh12.6% off high

What Paras Healthcare does

Employees: 4,141

Paras Healthcare at a glance

Size Paras Healthcare (PARASHLTH.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $962M, the 617th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹829.80 on 18 Nov 2026.

Growth Revenue grew 24.1% over the last twelve months (peer median +11.9%); the operating margin is 11.0% (peer median 10.5%).

Valuation It trades at 6.4× enterprise value to sales against a peer median of 3.1× (3rd most expensive of 21).

Capital Return on invested capital runs 4.9 points below its cost of capital (12.6% WACC).

Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).

Paras Healthcare financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenuen/a₹16.1B₹12.9B₹11.3B₹9.18B
Revenue growth—+24%+15%+23%—
Gross profitn/a₹7.20B₹2.62B₹4.50B₹3.69B
EBITDAn/a₹3.20B₹1.41B₹1.23B₹1.25B
Net incomen/a₹438M-₹580M-₹153M-₹428M
Free cash flown/a-₹531M-₹791M-₹1.34B-₹834M
Capital expendituren/a₹1.69B₹1.37B₹1.98B₹1.13B
Total debt₹15.2B₹13.9B₹12.3B₹9.24B₹7.56B

Quarterly statements and history in the cockpit →

Paras Healthcare competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Fundamentals: revenue growth against valuation

0%+10%+20%2×4×6×GDSHCGA50CBAVJLHLRHKPARKHOSPSYATHARTHKOVAICVSGBSLSPI301293RAINBOWAEVS000516SIAARTEMISMED301267PARASHLTH.NSRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Paras Healthcare is the large dot.

Paras Healthcare competitors and peer comparison

How Paras Healthcare compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Paras Healthcare against its 20 peers (data as of 18 Nov 2026)
MeasurePARASHLTH.NSPeer medianRank in peer set
Distance from 52-week high-12.6%-14.9%9th highest of 21
Revenue growth (TTM)+24.1%+11.9%2nd highest of 21
Operating margin11.0%10.5%10th highest of 21
EV / Sales6.4×3.1×3rd most expensive of 21
ROIC minus cost of capital-4.9 pp-2.2 pp5th lowest of 21
EV / EBITDA31.9×18.3×most expensive of 16
Net debt / EBITDA3.8×1.6×6th most indebted of 17

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Paras Healthcare PARASHLTH.NSIndia$962Mn/a+24%11%6.4×n/an/a
Ramsay Generale de Sante GDS.PAFrance$969M-25%+3%4%0.9×6.1%+6.0%
HealthCare Global Enterprises HCG.NSIndia$955M-7%+13%8%3.9×n/an/a
Thomson Medical A50.SISingapore$923M-18%+6%10%5.5×21.2%+11.8%
Clinica Baviera CBAV.MCSpain$1.01B+2%+11%20%2.8×2.3%+19.7%
Jupiter Life Line Hospitals JLHL.NSIndia$1.01B+9%+17%16%6.0×n/an/a
Rhon-klinikum RHK.DEGermany$1.06B+15%+4%-51%0.6×n/an/a
Park Medi World PARKHOSPS.NSIndia$1.10B-4%+21%21%5.8×22.1%+10.2%
Yatharth Hospital and Trauma Care Services YATHARTH.NSIndia$1.13B+31%+50%16%7.2×n/an/a
Kovai Medical Center & Hospital KOVAI.NSIndia$759M+22%+17%21%4.1×17.4%+18.1%
CVS CVSG.LUnited Kingdom$1.22B+17%+6%11%1.7×14.2%+6.9%
Raffles Medical BSL.SISingapore$1.23B-13%-3%11%1.8×-2.7%+6.1%
Spire Healthcare SPI.LUnited Kingdom$1.31B+11%+2%8%1.4×10.0%+11.4%
Sanbo Hospital Management 301293.SZChina$1.35B-29%+17%6%4.9×n/an/a
Rainbow Childrens Medicare RAINBOW.NSIndia$1.37B-7%+23%22%7.0×30.7%+21.2%
Aevis Victoria AEVS.SWSwitzerland$1.43B+8%+15%-6%1.8×26.5%+10.2%
Xi'an International Medical Investment 000516.SZChina$1.46B-2%-1%-2%3.1×12.7%+20.6%
Sienna Senior Living SIA.TOCanada$1.58B-8%+15%10%3.1×18.9%+8.6%
Artemis Medicare Services ARTEMISMED.NSIndia$582M+25%+15%13%4.8×48.5%+21.5%
Huaxia Eye Hospital 301267.SZChina$1.78B-18%+2%15%2.1×2.1%+10.4%
Garofalo Health Care GHC.MIItaly$508M-3%+4%10%1.4×1.7%+18.3%

Questions

Which companies are Paras Healthcare's closest peers?
The cockpit's peer set: Ramsay Generale de Sante (GDS.PA), HealthCare Global Enterprises (HCG.NS), Thomson Medical (A50.SI), Clinica Baviera (CBAV.MC), Jupiter Life Line Hospitals (JLHL.NS), Rhon-klinikum (RHK.DE), Park Medi World (PARKHOSPS.NS), Yatharth Hospital and Trauma Care Services (YATHARTH.NS).
Is Paras Healthcare expensive compared with its peers?
On ev / sales it trades at 6.4× against a peer median of 3.1×, 3rd most expensive of 21 in its peer set.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.